Edition:
United States

Acasti Pharma Inc (ACST.O)

ACST.O on Consolidated Issue listed on NASDAQ Capital Market

1.32USD
19 Sep 2017
Change (% chg)

$0.03 (+2.39%)
Prev Close
$1.29
Open
$1.28
Day's High
$1.34
Day's Low
$1.28
Volume
5,603
Avg. Vol
24,338
52-wk High
$2.46
52-wk Low
$1.11

Select another date:

Mon, Aug 14 2017

BRIEF-Acasti Pharma reports Q1 loss per share c$0.19

* Acasti Pharma reports first quarter fy 2018 financial results

BRIEF-Acasti Pharma issues common shares in payment of outstanding interest under debentures

* Acasti Pharma announces issuance of common shares in payment of outstanding interest under debentures Source text for Eikon: Further company coverage:

BRIEF-Acasti Pharma reports Q4 and FY 2017 financial results

* Acasti Pharma reports fourth quarter and full-year 2017 financial results

BRIEF-Acasti Pharma, CordenPharma announce large scale production of CaPre with new continuous manufacturing process

* Acasti Pharma and CordenPharma announce large scale production of Capre with new continuous manufacturing process Source text for Eikon: Further company coverage:

BRIEF-Acasti Pharma says has successfully completed two Phase 1, two Phase 2 clinical trials with Capre

* Acasti Pharma Inc - has successfully completed two Phase 1 and two Phase 2 clinical trials with Capre for treatment of hypertriglyceridemia

BRIEF-Acasti Pharma provides update on Capre phase 3 development program

* Acasti Pharma provides update on Capre phase 3 development program

Select another date: